Logo - springer
Slogan - springer

Life Sciences - Cell Biology | Clinical Proteomics (Editorial Board)

Clinical Proteomics

Clinical Proteomics

Editor-in-Chief: Daniel W. Chan

ISSN: 1559-0275 (electronic version)

Journal no. 12014

BioMed Central

Open access BioMed Central

Prof Daniel W Chan, Johns Hopkins University, USA

Associate Editors
Prof Tim Griffin, University of Minnesota, USA 
Dr Danni Li, University of Minnesota, USA 
Prof John G Marshall, Ryerson University, Canada
Dr Stephen R Master, Children’s Hospital of Philadelphia, USA
Prof Ed Nice, Ludwig Institute for Cancer Research, Australia
Prof Akhilesh Pandey, Mayo Clinic, USA 
Prof Stephen Pennington, University College Dublin, Ireland
Dr Alex Rai, Columbia University, USA
Dr Karin Rodland, Pacific Northwest National Laboratory, USA
Prof KW Michael Siu, University of Windsor, Canada 
Dr Pothur Srinivas, National Institutes of Health, USA
Prof Hui Zhang, Johns Hopkins Medical Institutions, USA

Senior Editors
Prof Mark S Baker, Macquarie University, Australia
Prof Denis Hochstrasser, Geneva University, Switzerland
Prof Gilbert S Omenn, University of Michigan, USA
Dr Richard D Smith, Pacific Northwest National Laboratory, USA

Editorial Board

Prof Dr Ruedi Aebersold, ETH Zurich, Switzerland
Dr Leigh Anderson, Plasma Proteome Institute, USA
Dr Christoph Borchers, University of Victoria, Canada
Dr Maria Chan, Food and Drug Administration, USA 
Dr Ben Collins, ETH Zurich, Switzerland
Prof Catherine E Costello, Boston University, USA
Dr Mari DeMarco, University of British Columbia, Canada
Prof Eleftherios P Diamandis, University of Toronto, Canada
Dr Andrei Drabovich, University of Alberta, Canada
Dr Brian Haab, Van Andel Institute, USA
Prof Samir Hanash, Fred Hutchinson Cancer Research Center, USA
Prof Fuchu He, Beijing Institute of Radiation Medicine, China
Prof Michelle Hill, QIMR Berghofer Medical Research Institute, Australia
Dr Andrew Hoofnagle, University of Washington, USA
Prof Connie Jimenez, VU University Medical Center, The Netherlands
Dr Jacob Kagan, National Cancer Institute, USA
Dr Mahesh Kulkarni, CSIR-National Chemical Laboratory, India
Dr Scott Kuzdzal, Shimadzu Scientific Instruments, UK
Prof Joshua LaBaer, Arizona State University, USA
Prof Yan Li, Chinese Academy of Sciences, China
Prof Joseph Loo, University of California Los Angeles, USA
Dr Mary F Lopez, Nuclea Biotechnologies, USA
Prof Peter Luppa, Technische Universität München, Germany  
Prof Michael Moran, University of Toronto, Canada
Prof Fumio Nomura, Chiba University, Japan
Prof Nicolle Packer, Macquarie University, Australia
Prof Young-Ki Paik, Yonsei University, South Korea
Prof Peipei Ping, University of California Los Angeles, USA
Prof Terence CW Poon, University of Macau, China
Dr Henry Rodriguez, National Cancer Institute, USA
Prof Jean-Charles Sanchez, Centre Medical Universitaire, Switzerland
Dr Richard Semba, Johns Hopkins School of Medicine, USA
Prof John Semmes, Eastern Virginia Medical School, USA
Dr Steven Skates, Harvard University, USA
Prof Michael Snyder, Stanford University, USA
Dr Sudhir Srivastava, National Institute of Health, USA
Dr Chris Sutton, University of Bradford, UK
Prof Naoyuki Taniguchi, RIKEN Advanced Science Institute, Japan
Prof Jennifer van Eyk, Cedars-Sinai Medical Center, USA
Dr Timothy D Veenstra, National Institutes of Health, USA
Prof Marc R Wilkins, University of New South Wales, Australia
Dr Bing Zhang, Vanderbilt University, USA
Dr Zhen Zhang, Johns Hopkins Medical Institutions, USA
Prof Yingming Zhao, The University of Chicago, USA 
Prof Heng Zhu, Johns Hopkins University, USA

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 3.516
  • Aims and Scope

    Aims and Scope


    Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.

     A key feature of Clinical Proteomics is its commitment to rapid scientific review and timely publication of submitted manuscripts. This is achieved receiving and processing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on cellular networks.

    Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal places special emphasis on the application of proteomic technology to all aspects of clinical research. A key feature is its commitment to rapid scientific review and timely publication of submitted manuscripts.

  • Submit Online
  • English Language Editing

    English Language Editing


  • Writing Resources: Training for Authors